TrialClinical rheumatology2024

A prospective randomized-controlled non-blinded comparative study of the JAK inhibitor (baricitinib) with TNF-α inhibitors and conventional DMARDs in a sample of Egyptian rheumatoid arthritis patients.

Esraa M Mahmoud et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.